NCT06313918 Exercise Therapy in Mental Disorders-study
| NCT ID | NCT06313918 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haukeland University Hospital |
| Condition | Schizophrenia and Related Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-09-27 |
| Primary Completion | 2026-09-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-09-27 with a primary completion date of 2026-09-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will compare standard high-intensity training with brief high-intensity training in people with schizophrenia-spectrum or bipolar disorder. The overall aim is to determine which of the two is superior in a long-term perspective.
Eligibility Criteria
Inclusion Criteria: * ICD-10 schizophrenia-spectrum disorder (F2) * ICD-10 bipolar disorder (F3) * Capacity to provide informed consent. Exclusion Criteria: * Contra-indication for exercise training and testing according to the American College of Sports Medicine specifications * Life threatening or terminal medical conditions * Not able to carry out intervention or test procedures * Current pregnancy * Mothers less than 6 months post-partum.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06313918 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Schizophrenia and Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06313918 currently recruiting?
Yes, NCT06313918 is actively recruiting participants. Contact the research team at erik.johnsen@helse-bergen.no for enrollment information.
Where is the NCT06313918 trial being conducted?
This trial is being conducted at Bergen, Norway.
Who is sponsoring the NCT06313918 clinical trial?
NCT06313918 is sponsored by Haukeland University Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.